| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | WO2002045654A9 Cancer preventative effect of morinda citrifolia |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040030164 Process for the preparation of taxan derivatives |
| 02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance |
| 02/12/2004 | US20040029967 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/12/2004 | US20040029965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029914 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/12/2004 | US20040029910 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029860 Anti-proliferative drugs |
| 02/12/2004 | US20040029858 Antitumor agents; solid tumors of rectum, lungs |
| 02/12/2004 | US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029852 Anticancer agents |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029835 Antitumor agents |
| 02/12/2004 | US20040029828 Homeostasis-maintaining agents |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029821 Pharmaceutical composition containing an indolopyrrolocarbazole derivative |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029770 Genetic engineering; anticancer agents |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029244 Phospholipase d effectors for therapy and screening |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029222 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040029112 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040028750 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028693 Fusion protein viricides |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028674 Biological materials and the use thereof for the treatment of disease |
| 02/12/2004 | US20040028663 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028653 Self-rearranging DNA vectors |
| 02/12/2004 | US20040028649 Regenerating cells |
| 02/12/2004 | US20040028647 Vaccines against cytokines and growth factors derived from malignant tumours |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | DE10235602A1 Use of transition metal cluster compounds capable of interacting with DNA to prevent or treat human or animal diseases, especially tumors |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494616A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |